伴颈部Ⅵ区淋巴结转移的甲状腺乳头状癌临床分析  

Clinical analysis of thyroid papillary carcinoma with cervical Ⅵ region lymph node metastasis

作　　者：王文超[1] 杨丽[1] 张春霞[1] 

机构地区：[1]北京市顺义区医院普外二科,北京101300

出　　处：《现代肿瘤医学》2017年第1期45-47,共3页Journal of Modern Oncology

摘　　要：目的:分析伴颈部Ⅵ区淋巴结转移的甲状腺乳头状癌患者的临床特点及其相关因素。方法:回顾性分析2004年1月至2014年10月顺义区医院收治的121例甲状腺乳头状癌患者的临床资料,其中伴颈部Ⅵ区淋巴结转移者56例。结果:肿瘤最大径越大,甲状腺乳头状癌患者的颈部Ⅵ区淋巴结转移率越高(P<0.05),病灶位于峡部或肿瘤侵犯包膜的患者颈部Ⅵ区淋巴结转移率高(P<0.05)。患者性别、年龄、甲状腺结节数目与是否伴颈部Ⅵ区淋巴结转移无关(P>0.05)。结论:甲状腺肿瘤大小、病灶位置及是否侵犯包膜是辅助评估甲状腺乳头状癌患者是否伴有颈部Ⅵ区淋巴结转移的重要指标。Objective： To analyze the clinical features of the patients with thyroid papillary carcinoma（ TPC） combined with cervical Ⅵ region lymph node metastasis and the relationship with the clinical factors. Methods： We performed a retrospective analysis of the clinical data of 121 patients presenting with TPC. There were 56 patients who were combined with cervical Ⅵ region lymph node metastasis. Results： The larger the maximum diameter of the tumor in patients with TPC was associated with greater risk of the possibility of suffering cervical Ⅵ region lymph node metastasis（ P〈0. 05）. The possibility of suffering cervical Ⅵ region lymph node metastasis increased when the nodules located in isthmus or the tumor penetrating through the thyroid capsule（ P〈0. 05）. The gender,age and the number of tumor were not correlated with the possibility of cervical Ⅵ region lymph node metastasis（ P〉0. 05）. Conclusion：For the patient with TPC,the size,location of the tumor or the tumor penetrating through the thyroid capsule are important indicators for auxiliary assessment whether or not be combined with cervical Ⅵ region lymph node metastasis.

关 键 词：甲状腺乳头状癌 淋巴结 转移 

分 类 号：R736.1[医药卫生—肿瘤]